r In the heart, endothelial nitric oxide (NO) controls oxygen consumption in the working heart through paracrine mechanisms.
Introduction
The heart consumes large amounts of energy in the form of ATP that is produced in mitochondria. In the mitochondrial matrix, the Krebs cycle produces NADH and FADH 2 , which deliver electrons to the electron transport chain (ETC; Fig. 1 ). Through sequential redox reactions along complexes I-IV of the ETC, a proton gradient is established that together with the electrochemical gradient ( m ) constitutes the protonmotive force which is the driving force for ATP production at the F 1 F o ATP-synthase. To match ATP production to the constantly varying ATP demand, efficient regulatory mechanisms are in place, and two dominant regulators are ADP and Ca 2+ (Brandes & Bers, 1997; Maack et al. 2006; Balaban, 2009; Nickel et al. 2013) . When ATP consumption increases, ADP stimulates ATP production at the F 1 F o ATP-synthase, which accelerates electron flux along the ETC and oxidizes NADH to NAD + (Maack et al. 2006) . A physiological increase in cardiac workload is triggered by β-adrenergic stimulation, which increases the amplitude and frequency of cytosolic Ca 2+ transients. Mitochondria take up Ca 2+ via the Ca 2+ uniporter (MCU) (Baughman et al. 2011; De Stefani et al. 2011) , and in the matrix, Ca 2+ stimulates rate-controlling dehydrogenases of the Krebs cycle that accelerate the regeneration of NAD + to NADH (Fig. 1) . Thus, during β-adrenergic stimulation, the complementary control of respiration and Krebs cycle activity by ADP and Ca 2+ maintains stable ATP/ADP and NADH/NAD + ratios (Maack et al. 2006; Balaban, 2009) .
During respiration, superoxide anion radicals (O 2 − ) are generated at complexes I and III of the ETC (Turrens, 2003; Balaban et al. 2005; Murphy, 2009 (Nickel et al. 2014) . Since NADPH is regenerated by enzymes that derive their substrates from the Krebs cycle, mitochondrial Ca 2+ uptake serves not only to regenerate NADH for ATP production, but also NADPH for H 2 O 2 detoxification Nickel et al. 2014) (Fig. 1) . Based on these and other results, the concept of 'redox-optimized ROS balance' was developed which implies that ROS emission from mitochondria depends strongly on the redox state of both NADH/NAD + and NADPH/NADP + , and oxidative stress occurs when this balance is disturbed towards either a highly reduced or a highly oxidized redox environment in the mitochondrial matrix (Aon et al. 2010; Gauthier et al. 2013) . In heart failure, changes in cytosolic Na + and Ca 2+ handling and pathological elevations of afterload promote a pro-oxidative shift in the NAD(P)H/NAD(P) + redox state, giving rise to energetic deficit and oxidative stress (Nickel et al. 2014 (Nickel et al. , 2015 .
An important endogenous signalling molecule that can interfere with electron flux at the ETC, and thereby, the redox states of NADH/NAD + and NADPH/NADP + , is nitric oxide (NO). By competing with oxygen (O 2 ) at complex IV of the ETC (i.e. cytochrome oxidase), NO slows electron flux, reduces O 2 consumption and is catabolized to the nitrite ion (Torres et al. 1995; Pearce et al. 2002) . Furthermore, NO-dependent modifications of complexes I and III may further decrease electron flux along the ETC (Poderoso et al. 1996; Chouchani et al. 2013; Iglesias et al. 2015) . The canonical source for NO in the cardiovascular system is the endothelial NO synthase (eNOS) originally identified in endothelial cells. In the working heart, endogenous formation of NO from the coronary microvasculature lowers cardiac O 2 consumption (Shen et al. 1994) . In heart failure, endothelial dysfunction is associated with decreased eNOS expression and NO release (Mohri et al. 1997; Poderoso et al. 1998) , and in isolated myocardial preparations, the bradykinin-induced stimulation of eNOS-mediated vascular NO release is blunted . But apart from endothelial cells, NO is produced also within cardiac myocytes. Here, the dominant sources are eNOS and neuronal NOS (nNOS), where eNOS is located in caveolae of the cell membrane, while nNOS co-localizes with ryanodine receptors (RyR2) of the sarcoplasmic reticulum (SR) (Xu et al. 1999; Barouch et al. 2002) . While on the one hand NO production from eNOS and, in particular, nNOS is activated by Ca 2+ , NO in turn impacts Ca 2+ handling, and in heart failure, alterations of NO signalling may contribute to contractile dysfunction and arrhythmias (Simon et al. 2014) .
A long-standing controversy is the putative existence of a NOS located within mitochondria (mtNOS) (Brookes, 2004; Zaobornyj & Ghafourifar, 2012 ? ?
? ? Figure 1 . Regulation of mitochondrial respiration and ROS formation and possible ways by which NO from different sources may affect these processes The Krebs cycle generates NADH, which donates electrons to the electron transport chain (ETC) for oxidative phosphorylation of ATP. Regeneration of the anti-oxidative capacity is also coupled to the Krebs cycle via nicotinamide nucleotide transhydrogenase (Nnt), isocitrate dehydrogenase (IDP m ) and malic enzyme (MEP). A putative mitochondrial NOS (mtNOS) is located in the inner mitochondrial membrane and therefore should be activated by matrix Ca 2+ , whereas a neuronal NOS (nNOS) located at ryanodine receptors (RyR) of the sarcoplasmic reticulum (SR) should be activated by cytosolic Ca 2+ . Intramitochondrial NO may inhibit respiration at complex IV (shown here), but potentially also at complex III and possibly I (see text). Slowing respiration with NO may increase NADH, and via the Nnt, also NADPH. m , mitochondrial membrane potential; pH, proton gradient; Nnt, nicotinamide nucleotide transhydrogenase; Mn-SOD, Mn 2+ -dependent superoxide dismutase; PRX, peroxiredoxin; GPX, glutathione peroxidase; TRX r/o , reduced/oxidized thioredoxin; GSH/GSSG, reduced/oxidized glutathione; TR, thioredoxin reductase; GR, glutathione reductase; MCU and NCLX, mitochondrial Ca 2+ uniporter and Na + /Ca 2+ exchanger, respectively; L-Arg, L-arginine; OMM, outer mitochondrial membrane; Mfn, mitofusin; SERCA, SR Ca 2+ ATPase; LTCC, L-type Ca 2+ channels. J Physiol 595.12 immunofluorescence techniques 20 years ago (Bates et al. 1996) , enzymatic studies revealed NOS activity in the inner mitochondrial membrane, where it exerted substantial control over mitochondrial respiration and m by interacting with cytochrome oxidase, and where mtNOS was activated by mitochondrial Ca 2+ uptake (Ghafourifar & Richter, 1997; Giulivi, 1998) (Fig. 1 ). An elegant study using porphyrinic microsensor measurements revealed that NO was rapidly released from isolated cardiac mitochondria after applying extra-mitochondrial Ca 2+ pulses, and genetic deletion of nNOS, but neither eNOS nor inducible NOS (iNOS) eliminated this Ca 2+ -induced NO release (Kanai et al. 2001 uptake and NO production, which was sensitive to pharmacological inhibition of the MCU, Ca 2+ /calmodulin or nNOS, but neither eNOS nor iNOS (Dedkova & Blatter, 2009) . Although some studies could not identify relevant amounts of NO being produced by an mtNOS in porcine (French et al. 2001) or human cardiac mitochondria (Csordás et al. 2007) , it is currently the prevailing view that an NOS does exist in cardiac mitochondria, presumably nNOS, activated by matrix Ca 2+ and able to control respiration under physiological conditions (Zaobornyj & Ghafourifar, 2012) .
It is difficult, however, to estimate whether the amount of mitochondrial Ca 2+ uptake under the experimental conditions used in previous studies (Kanai et al. 2001; Dedkova & Blatter, 2009 ) adequately reflects the physiological situation in cardiac myocytes, where mitochondria are embedded in their physiological three-dimensional context in which microdomains for both Ca 2+ and ADP confer important control over mitochondrial respiration and redox state during excitation-contraction (EC) coupling (Saks et al. 2006; Kohlhaas & Maack, 2013) . Therefore, the primary aims of the present study were to reveal whether (i) NO formation in mitochondria from an mtNOS can be detected during EC coupling under physiological conditions, i.e. in response to β-adrenergic stimulation in live cells, (ii) whether endogenous (intra-or extramitochondrial) NO formation controls respiration and the redox state of NAD(P)H/NAD(P) + , and (iii) since NADPH critically controls mitochondrial ROS emission (Nickel et al. 2014) , whether changes in the redox state of NAD(P)H/NAD(P)
+ have an impact on mitochondrial ROS emission (Fig. 1) .
For this purpose, we combined fluorescence imaging of isolated cardiac myocytes with a patch-clamp-or field-stimulation-based approach together with transgenic technology. Our results argue against relevant NO formation from a mitochondria-located NOS (i.e. mtNOS) under physiological conditions, but reveal that extramitochondrial nNOS has the highest contribution towards cellular NO formation during β-adrenergic stimulation in cardiac myocytes. While some of this NO permeates to mitochondria, these amounts are insufficient to regulate electron flux at the ETC. However, at supra-physiological extracellular Ca 2+ concentrations, transient nNOS-dependent regulation of the NAD(P)H redox state was observed, indicating that either mtNOSor SR-located nNOS-derived NO production becomes relevant under pathological conditions, such as cytosolic and mitochondrial Ca 2+ overload (Dedkova & Blatter, 2009 ) and/or during ischaemia/reperfusion (Burkard et al. 2010) . Our data do not exclude the possibility that respiration in cardiac myocytes is affected by NO from non-myocyte sources in a paracrine fashion, i.e. from an eNOS located in endothelial cells of the myocardium .
Methods

Ethical approval
Animal procedures were approved by the local animal ethics committee and conducted in accordance with institutional guidelines and the principles and regulations, as described by Grundy (2015) .
Anaesthesia and killing of animals
Guinea pigs and mice (cardiomyocyte isolation) received carprofen (12 mg kg −1 body weight) and heparin (10 000 IE kg −1 body weight) and were anaesthetized with isoflurane (5% at 0.5 l min −1 ). When animals were insensible to pedal reflexes, hearts were rapidly excised and processed for further experiments as indicated in the specific sections below. For mitochondria isolation from mouse hearts, animals were killed by intraperitoneal injection of a mixture of ketamine hydrochloride (100 mg kg −1 body weight; Pfizer, Karlsruhe, Germany) and xylazine hydrochloride ('Rompun' , 10 mg kg −1 body weight; Bayer Healthcare, Berlin, Germany), and hearts were rapidly excised and processed for further experiments as indicated in the specific sections below.
Animals
Guinea pigs and mice were obtained from Charles River (Sulzfeld, Germany) and housed under standard conditions. Mice with genetic disruption of eNOS (eNOS −/− ) were obtained from Jackson Laboratories through Charles River (strain name: B6.129P2-Nos3 tm1Unc /J; Stock no. 002684) and compared to C57BL/6J mice as wild-type controls. Mice with genetic disruption of nNOS (nNOS −/− ) were described previously (Huang et al. 1993; Sears et al. 2003 ) and compared to nNOS +/+ littermate controls, which were on a mixed background of C57BL/6J/129, respectively.
Experiments on isolated cardiac myocytes
Experiments on adult ventricular cardiac myocytes from mice and guinea pigs, including enzymatic digestion, storage, use of microscope systems, incubation and recordings of fluorescent dyes or autofluorescence, were described in more detail previously Chen et al. 2012; Nickel et al. 2015) . In general, for the experiments in Figs 2, 3, 6, 7 and 8 isolated cardiac myocytes were field-stimulated at 37°C and exposed to a protocol that simulates a physiological workload increase by first pacing cells at 0.3 Hz (guinea pigs) or 0.5 Hz (mice), respectively. The superfusing Normal Tyrode´s solution contained (in mM): NaCl 130, KCl 5, MgCl 2 1, CaCal 2 2 in guinea pig myocytes and 1 in mice (except 3 mM in experiments of Fig. 8 as indicated) , Na-HEPES 10, glucose 10, sodium pyruvate 2 and ascorbic acid 0.3, pH 7.4. The β-adrenergic receptor agonist isoproterenol (100 nmol l −1 ) was then washed in, and after 1 min, the stimulation rate was increased to 3 Hz (guinea pigs) or 5 Hz (mice) for 3 min. After this time, stimulation rate was set back to the initial slower rate, and isoproterenol was washed out again. During these measurements, sarcomere length was recorded using an IonOptix set-up, with which sarcomere detection (using a CCD-camera) was combined with fluorescence recordings of either the cellular autofluorescence of NAD(P)H and FAD, or alternatively, of fluorescent dyes.
For recordings of NO, the fluorescent NO-sensitive dye 4-amino-5-methylamino-2 ,7 -difluorofluorescein diacetate (DAF; Life Technologies, Germany; catalogue number D23844) was used. Cardiac myocytes were incubated with 1 μmol L −1 DAF at 37°C for 20 min. Previous studies have shown that by a similar loading protocol, DAF locates to both the cytosol and mitochondria (Dedkova & Blatter, 2009) . DAF was excited at a wavelength of 488 nm, and emission collected at 510 nm. At the end of every experiment, the NO-donor spermine/NONOate (Sper/NO) was added at 1 mmol l −1 to obtain a maximal DAF response. Cells without a relevant fluorescence response to Sper/NO were excluded from analysis.
For experiments on intact cardiac myocytes, the DAF signal derives from both the cytosol and the mitochondria (Dedkova & Blatter, 2009 ). To determine mitochondrial NO levels, we applied a patch-clamp-based approach adapted from our previous studies using rhod-2 as a mitochondria-located Ca 2+ indicator, whose cytosolic traces were efficiently eliminated by whole-cell dialysis with a dye-free pipette solution containing (in mM): potassium glutamate 130, KCl 19, MgCl 2 0.5, Na-HEPES 15, Mg-ATP 5, pH 7.2 (Maack et al. 2006; . Here, we loaded cardiac myocytes with cell-permeable DAF and then voltage-clamped cells in the whole-cell configuration (37°C, pipette resistance 2-4 M ), equilibrating the cytosol with a DAF-free physiological K + -glutamate-based pipette solution with intracellular [Na + ] set to 5 mmol l −1 in guinea pig myocytes or 15 mmol l −1 in mouse cardiac myocytes (Chen et al. 2012) . With this cytosolic dialysis, we reduced DAF fluorescence by similar extents (albeit with slower kinetics) compared to . Endogenous NO formation in guinea pig cardiac myocytes Isolated guinea pig cardiac myocytes were loaded with DAF and exposed to a physiological stress protocol by increasing electrical field stimulation frequency from 0.3 to 3 Hz during exposure to the β-adrenergic agonist isoproterenol (Iso, 100 nmol l −1 ), in the absence (Control; n = 32) and presence of the NOS substrate L-arginine (L-Arg, 100 μmol l −1 ; n = 17), the non-selective NOS-inhibitor L-NAME (100 μmol l −1 ; n = 7) and the eNOS-inhibitor L-NIO (1 μmol l −1 ; n = 13), respectively. A, stimulation protocol and representative trace of a control cell illustrating sarcomere length. B, average data for systolic sarcomere shortening. There were no differences in the diastolic sarcomere length in all groups. C, endogenous NO formation detected with DAF. A control group of myocytes was exposed to isoproterenol, but not electrically stimulated (no pacing; n = 19). # P < 0.05 for L-NAME vs. Control, L-Arg and L-NIO (two-way ANOVA), and P < 0.001 no pacing vs. Control, L-Arg and L-NIO (two-way ANOVA), with P < 0.05 for the time points from 134 s (Control), 116 s (L-Arg) and 140 s (L-NIO) in Bonferroni's post-test, respectively. J Physiol 595.12 membrane permeabilization with digitonin (10 nmol l −1 ; Fig. 4B ), as performed in the studies by Dedkova & Blatter (2009) . In some of these experiments, the MCU inhibitor Ru360 (1 μmol l −1 ) was included in the pipette solution, under which conditions we effectively inhibited mitochondrial Ca 2+ uptake in previous studies Chen et al. 2012) . In other experiments, the global NOS-inhibitor L-NAME (100 μmol l −1 ), the eNOS-specific inhibitor L-N5-(1-Iminoethyl)ornithine hydrochloride (L-NIO) (1 μmol l −1 ), the nNOS-specific inhibitor 7-Nitroindazole (7-NI) (2 μmol l −1 ) or the NOS substrate L-arginine (L-Arg; 100 μmol l −1 ) were included in the bath solution (and in patch-clamp experiments, also the pipette solutions), respectively. For the experiments in Fig. 4 , myocytes were depolarized from −80 to +10 mV at 3 Hz for 80 ms in guinea pig myocytes or at 5 Hz for 50 ms in mouse myocytes, respectively, and isoproterenol (100 nmol l −1 ) was used to increase workload via β-adrenergic stimulation.
To determine the mitochondrial redox states of NAD(P)H/NAD(P) + and FADH 2 /FAD, the NAD(P)H and FAD autofluorescence was determined in the 
. Most endogenous NO formation in mouse cardiac myocytes derives from nNOS, but not eNOS
Isolated mouse cardiac myocytes were loaded with DAF and exposed to a stress protocol as described in the legend to Fig. 2 , except that stimulation frequency was elevated from 0.5 to 5 Hz. A, changes in DAF fluorescence in wild-type (WT) myocytes in the absence (Control, n = 18) and presence of the nNOS inhibitor 7-NI (2 μmol l −1 ; n = 17) or the non-selective NOS-inhibitor L-NAME (100 μmol l −1 ; n = 20), respectively, and in eNOS KO myocytes in the absence (n = 18) or presence of the nNOS inhibitor 7-NI (2 μmol l −1 ; n = 19), respectively. B, changes in DAF fluorescence in myocytes from mice with cardiomyocyte-specific deletion of nNOS (nNOS −/− ) or from WT littermate controls (nNOS +/+ ), in the absence (nNOS −/− Control, n = 19; nNOS +/+ Control, n = 18) or presence of the eNOS inhibitor L-NIO (1 μmol l −1 ; nNOS −/− +L-NIO, n = 17; nNOS +/+ +L-NIO, n = 12) or the non-specific NOS-inhibitor L-NAME (100 μmol l −1 ; nNOS +/+ +L-NAME, n = 16), respectively. C and D, systolic sarcomere shortening at 0.5 Hz in the absence of isoproterenol, at 0.5 Hz after 1 min of isoproterenol (100 μmol l −1 ), at 5 Hz in the presence of isoproterenol and 1 min after stepping back to 0.5 Hz and washing out of isoproterenol in the same groups as in A and B, respectively. A: # P < 0.05 for WT Control vs. WT +L-NAME, eNOS −/− vs. WT L-NAME and P < 0.01 for eNOS −/− vs. eNOS −/− +7-NI (two-way ANOVA), respectively, with P < 0.05 from 192 s (WT L-NAME vs. WT Control), 232 s (eNOS −/− vs. WT L-NAME) and 304 s on for eNOS −/− vs. eNOS −/− +7-NI in Bonferroni post-test, respectively. B: # P < 0.001 for nNOS +/+ Control vs. nNOS −/− Control, nNOS +/+ Control vs. nNOS +/+ L-NAME, nNOS +/+ + L-NIO vs. nNOS −/− Control, nNOS +/+ -L-NAME and P < 0.05 for nNOS +/+ + L-NIO vs. nNOS −/− + L-NIO in two-way ANOVA, respectively. P < 0.05 from 200 s (nNOS +/+ Control vs. nNOS −/− Control and nNOS +/+ Control vs. nNOS +/+ L-NAME), 180 s (nNOS +/+ + L-NIO vs. nNOS −/− Control, nNOS +/+ -L-NAME) and from 308 s for nNOS +/+ + L-NIO vs. nNOS −/− + L-NIO in Bonferroni post-tests, respectively.
WT +L-NAME 
. No evidence for mitochondrial NO formation by mtNOS under physiological conditions
Isolated cardiac myocytes from guinea pigs or mice were isolated and loaded with DAF. A, overall increase in fluorescence at 485 nm excitation and 525 nm emission, the optimum for DAF, before and after loading with DAF. B, change in DAF fluorescence after chemical sarcolemmal membrane permeabilization with digitonin (10 nmol l −1 ; n = 23), or after cell dialysis by whole-cell patch-clamping the cell (n = 6). Note that despite slower kinetics, the patch-clamp-induced elimination of DAF fluorescence was comparably efficient as the digitonin-induced protocol. C, conceptual scheme illustrating that under these experimental conditions, most DAF is located in mitochondria, with cytosolic DAF being dialysed via the patch pipette, and the activation of NOS-derived NO production was probed by either inhibiting the MCU with Ru360, or inhibiting all NOS with L-NAME or genetic deletion of nNOS, respectively. D, change in mitochondria-localized DAF fluorescence in response to an increase in stimulation frequency from 0 to 3 Hz in the presence of isoproterenol (Iso, 100 nmol l −1 ) in guinea pig cardiac myocytes in the absence (Control, n = 5) and presence of the NOS substrate L-arginine (L-Arg, 100 μmol l −1 ; n = 5) and the NOS-inhibitor L-NAME (100 μmol l −1 ; n = 5), respectively. E, change in mitochondria-localized DAF fluorescence in response to an increase in stimulation frequency from 0 to 5 Hz in the presence of isoproterenol (Iso, 100 nmol l −1 ) in mouse cardiac myocytes in the absence (Control, n = 7) and presence of L-NAME (100 μmol l −1 ; n = 5), respectively, the MCU-inhibitor Ru360 (1 μmol l −1 ; n = 8), respectively, and compared to myocytes from mice with cardiomyocyte-specific deletion of nNOS (nNOS −/− Control, n = 10). D: # P < 0.05 for Control vs. L-NAME and L-Arg. vs. L-NAME using two-way ANOVA on the last three time points (covering the last 20 s), respectively. E: # P < 0.05 for WT Control vs. nNOS −/− Control, WT Control vs. WT + L-NAME and WT + Ru360 vs. nNOS −/− Control, and P < 0.01 for WT + Ru360 vs. WT + L-NAME in two-way ANOVA, respectively, and P < 0.05 from 392 s (WT Control vs. nNOS −/− Control) and 200 s on (WT Control vs. WT + L-NAME and WT + Ru360 vs. WT + L-NAME), respectively. J Physiol 595.12 same cells, respectively, and calibrated at the end of every experiment with the mitochondrial uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (5 μmol l −1 ) and the complex IV inhibitor sodium cyanide (4 mmol l −1 ), as described previously (Chen et al. 2012; Nickel et al. 2015) . Alternatively, the mitochondrial membrane potential ( m ) was determined with tetramethylrhodamine methyl ester (TMRM; 100 nmol l −1 ) together with the cytosolic Ca 2+ concentration ([Ca 2+ ] c ), determined by indo-1 acetoxymethyl esther (Indo-1 AM, 5 μmol l −1 ). For the semi-quantitative assessment of m , TMRM fluorescence was determined in isolated cardiac myocytes before and after the combined application of FCCP (5 μmol l −1 ) and oligomycin (1.26 μmol l −1 ), as described previously (Chen et al. 2012; Nickel et al. 2015) .
Experiments on isolated mitochondria
Mitochondria were isolated from mouse or guinea pig hearts, and respiration was measured polarographically at 30°C with a Clark electrode as described previously (Nickel et al. 2015) . The mitochondrial contents were 400 μg of guinea pig heart mitochondria, and 400, 200 or 100 μg of mouse heart mitochondria. State 2 respiration was initiated by the addition of 5 mM sodium pyruvate and 5 mM sodium malate. After 3 min, 1.5 mM ADP was added to induce maximal state 3 respiration. After 1 min, different concentrations of Sper/NO were added. In addition to the conditions before application of ADP, we obtained an additional estimation of state 4 respiration by adding the F 1 F o ATP-synthase inhibitor oligomycin (1.2 μM) after the addition of ADP.
Mitochondrial H 2 O 2 emission
H 2 O 2 emission from mitochondria was measured using the H 2 O 2 -sensitive and specific fluorescent dye Amplex UltraRed (AUR; Life Technologies, Molecular Probes, Carlsbad, CA, USA). AUR reacts with H 2 O 2 to form the fluorescent product Resorufin (excitation at 535 nm, emission at 590 nm) in a 1:1 ratio. The reaction is catalysed by HRP. Assay component concentrations were 10 μM for AUR, 0.5 U ml −1 for HRP and 100 U ml −1 SOD (for conversion of O 2 − to H 2 O 2 ). Mitochondrial H 2 O 2 production was measured in the presence of 1.5 mM ADP and/or known concentrations of Sper/NO in the presence of pyruvate/malate (5 mmol l −1 , respectively) or mitochondria alone. Experiments were performed in 96-well plates (black/transparent) using the Tecan GENios Pro Reader (Tecan Group Ltd, Männedorf, Switzerland) with a top reading setting. All experiments were conducted in respiration buffer as described previously (Nickel et al. 2015) , with 30 μg mitochondria per well in triplicate at 37°C. H 2 O 2 was quantified from a calibration curve obtained with defined H 2 O 2 concentrations.
NAD(P)H measurements
NAD(P)H autofluorescence was measured using a fluorescence plate reader (infinite M200Pro, Tecan Group Ltd). All experiments were conducted in respiration buffer as described above with 80 μg mitochondria per well in triplicate (excitation at 340 nm, emission at 450 nm) in a 200 μl reaction volume. Pyruvate/malate (5 mmol l −1 , respectively), ADP (1.5 mmol l −1 ), Sper/NO (1, 2.5, 5 or 50 μmol l −1 ), cyanide (2.5 mmol l −1 ) and DNP (250 μmol l −1 ) were added at the indicated time points. Background fluorescence was subtracted and fluorescence was referred to the maximal value of each measurement.
Chemicals
L-NIO, spermine NONOare and Ru360 were purchased from Calbiochem, Germany. Indo-1, CM-H 2 DCFDA (DCF) and DAF were obtained from Life Technologies, Germany (catalogue numbers I1223, C6827 and D23844, respectively). All other chemicals were obtained from Sigma-Aldrich, Germany.
Statistical analyses
Values are displayed as mean ± SEM. Two-way ANOVA followed by Bonferroni´s multiple comparisons test, paired and unpaired t-tests were performed using GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla, CA, USA, www.graphpad.com).
Results
Endogenous formation of NO during β-adrenergic stimulation
Based on our previous experience and characterization of mitochondrial Ca 2+ uptake under various conditions (Maack et al. 2006; , initial experiments were performed on isolated cardiac myocytes from guinea pigs, in which the processes of EC coupling are comparable to human myocytes regarding the proportion of SR to trans-sarcolemmal Ca 2+ flux during a cytosolic Ca 2+ transient (Bers, 2008) . For detection of endogenous NO production, cardiac myocytes were loaded with the NO-sensitive indicator DAF, using conditions that favour mitochondrial dye compartmentalization (Dedkova et al. 2007; Dedkova & Blatter, 2009 ). During electrical field-stimulation of myocytes at 0.3 Hz that induced (cell-and) sarcomere shortening ( Fig. 2A and  B) , only a small increase in cellular DAF fluorescence was detected (Fig. 2C ). To simulate a physiological increase in workload, the β-adrenergic agonist isoproterenol was applied and stimulation frequency was increased to 3 Hz for 3 min. This increased sarcomere shortening ( Fig. 2A and B) , and in our previous studies we observed that under these conditions, the amplitudes of cytosolic and mitochondrial Ca 2+ transients increase, with accumulation of Ca 2+ in mitochondria within seconds to minutes (Maack et al. 2006; . Under these conditions, a robust increase in DAF fluorescence was observed that flattened out when stimulation frequency was stepped back to 0.3 Hz (Fig. 2C) . β-Adrenergic stimulation alone without any electrical field stimulation did not induce any increase in DAF fluorescence (Fig. 2C) , suggesting that an increase in cell shortening and cytosolic and/or mitochondrial Ca 2+ concentrations is required for NO formation.
Since in a previous study, supplementation with the NOS substrate L-Arg was required for a full NOS response in permeabilized myocytes (Dedkova & Blatter, 2009 ), we performed additional experiments in the presence of L-Arg in the bath solution (100 μM). However, no differences were observed in the absence or presence of L-Arg regarding sarcomere shortening (Fig. 2B) or accumulation of DAF fluorescence (Fig. 2C) , from which we concluded that in intact myocytes, the endogenous amounts of L-Arg are sufficient to support endogenous NO formation. Thus, all following experiments on intact myocytes were performed in the absence of exogenous L-Arg. Since DAF is not fully specific for NO, but may also be sensitive to ROS (Dedkova & Blatter, 2009 ), we added a non-specific inhibitor of NOS, L-NAME (100 μM), and observed that this suppressed most but not all of the increase in DAF fluorescence (Fig. 2C) . In the presence of L-NAME, sarcomere shortening was increased compared to control conditions at 0.3 Hz, but was similar during 3 Hz stimulation in the presence of isoproterenol (Fig. 2B) .
nNOS is the major source for endogenous NO during β-adrenergic stimulation To gain more insight into which NOS isoform may underlie cellular NO formation during β-adrenergic stimulation, we performed experiments in the presence of the eNOS inhibitor L-NIO (1 μmol l −1 ), which did not affect the increase in DAF fluorescence (Fig. 2C ) despite a similar increase in sarcomere shortening at 0.3 Hz as by the non-specific NOS inhibitor L-NAME (Fig. 2B) . Thus, we suspected that nNOS rather than eNOS might be the primary source for the NO that induces the increase in DAF fluorescence.
To test this appropriately, we performed experiments on myocytes from mice with targeted disruption of eNOS (eNOS −/− ) or nNOS (nNOS −/− ). In agreement with the data on guinea pig myocytes, eNOS deletion did not reduce the increase in DAF fluorescence compared to wild-type (WT) controls (non-littermate C57BL/6J mice), while the nNOS-inhibitor 7-NI (2 μmol l −1 ) partially reduced NO formation in WT myocytes (Fig. 3A) . In eNOS −/− myocytes, 7-NI led to a complete suppression of NO formation (Fig. 3A) . In nNOS −/− myocytes, the increase in DAF fluorescence was substantially reduced compared to littermate nNOS +/+ controls and similar as in nNOS +/+ myocytes in the presence of L-NAME (Fig. 3B) . In contrast, the eNOS inhibitor L-NIO (1 μmol l −1 ) did not reduce DAF fluorescence in WT or in nNOS −/− myocytes (Fig. 3B ). There were no significant differences in sarcomere shortening between the groups, respectively (Figs 3C and D) . Taken together, these data suggest that in cardiac myocytes, β-adrenergic stimulation increases endogenous NO formation from nNOS, but not eNOS. Dedkova & Blatter (2009) observed that by using loading conditions that favour mitochondrial dye compartmentalization, the NO indicator DAF locates to both mitochondria and the cytosol. To eliminate cytosolic DAF fluorescence, they permeabilized the cell membrane with digitonin, by which the overall fluorescence was decreased by ß50% (Dedkova & Blatter, 2009) . Accordingly, using similar conditions, we loaded intact guinea-pig cardiac myocytes with DAF ( Fig. 4A) and then permeabilized the cell membrane with digitonin (10 μmol l −1 ), reducing overall cellular DAF fluorescence in guinea pig myocytes by 40 ± 6% (n = 23) within 2-3 min (Fig. 4B) . Since in our previous work we observed that a coordinated SR Ca 2+ release is important for efficient mitochondrial Ca 2+ uptake , and under physiological conditions, this coordinated SR Ca 2+ release is triggered by Ca 2+ influx via voltage-gated Ca 2+ channels (Bers, 2008) , we wished to maintain physiological processes of EC coupling by employing a technique that we previously established to eliminate cytosolic traces of the mitochondria-located Ca 2+ indicator rhod-2 (Maack et al. 2006; . By patch-clamping myocytes in whole-cell configuration and dialysing the cytosol with a DAF-free pipette solution, a similar reduction of overall cellular DAF fluorescence as with membrane permeabilization could be achieved (36 ± 5%, n = 6; P = n.s. vs. permeabilization by digitonin, 40 ± 6%), albeit with slower kinetics compared to digitonin-induced cell permeabilization (Fig. 4B) . Under these conditions, we considered the increase of DAF fluorescence to stem primarily from mitochondria (Fig. 4C) . After patch-clamp-mediated elimination of cytosolic DAF, the relative increase in DAF fluorescence during β-adrenergic stimulation and increased stimulation frequency was clearly weaker than in intact (unpatched) guinea-pig myocytes, although J Physiol 595.12 this small increase was still sensitive to inhibition with L-NAME (Fig. 4D) . To rule out that the lower increase of DAF fluorescence was due to insufficient supply with endogenous L-Arg, we added this co-factor to the pipette and bathing solutions (100 μmol l −1 ). However, this did not further increase DAF fluorescence responses (Fig. 4D) .
No evidence for NO formation by a mitochondria-located NOS
When performing the same experiments in the absence and presence of L-NAME in cardiac myocytes from mice (rather than guinea pig), similar results were obtained (Fig. 4E) . In addition, the small increase in DAF fluorescence was also completely inhibited by genetic deletion of nNOS (Fig. 4E) , indicating that the NO detected within mitochondria stemmed from nNOS rather than eNOS. To differentiate whether the NO stems from an nNOS within (i.e. mtNOS) or outside mitochondria, we included the MCU inhibitor Ru360 (1 μmol l −1 ) in the pipette solution (Fig. 4C) , which in our previous studies prevented mitochondrial Ca 2+ accumulation in mouse and guinea pig myocytes Chen et al. 2012) . Ru360, however, did not prevent the increase in mitochondrial DAF fluorescence (Fig. 4E) , arguing against an mtNOS as a relevant source for NO under these conditions, since mtNOS would be expected to be inhibited by blockade of mitochondrial Ca 2+ uptake (Ghafourifar & Richter, 1997; Kanai et al. 2001; Dedkova & Blatter, 2009 ). Instead, these data suggest that the NO detected within mitochondria under these conditions stems from an nNOS located outside of mitochondria, possibly located at the closely associated RyRs of the SR (Xu et al. 1999; Barouch et al. 2002) .
Effects of exogenous NO formation on mitochondrial redox state
In our previous studies we identified a privileged Ca 2+ communication between the SR and mitochondria in cardiac myocytes that is in part facilitated by tethering of mitochondria to the SR by mitofusin-2 (Chen et al. 2012) and possibly other tethering proteins (Kohlhaas & Maack, 2013) . Since NO is a diffusible radical that can cross intracellular membranes, it seemed plausible that NO produced by an SR-located nNOS (Xu et al. 1999 ) may diffuse to the ETC and the mitochondrial matrix where it is then sensed by DAF. To probe whether extramitochondrial nNOS-derived NO formation was sufficient to regulate electron flux at the ETC in live cardiac myocytes, we reasoned that this NO should affect the redox state of NAD(P)H/NAD(P) + and FADH 2 /FAD (Fig. 1) , i.e. of parameters that can be easily monitored and reliably quantified in intact cardiac myocytes (Maack et al. 2006; .
To verify that NO affects the redox state of NAD(P)H/NAD(P) + at similar concentrations as it slows respiration, we isolated mitochondria from mouse and guinea pig hearts and determined O 2 consumption in the absence and presence of ADP (state 2 and state 3 respiration, respectively). In mitochondria supplemented with pyruvate and malate (5 mM, respectively), ADP accelerated respiration, with respiratory control ratios (state 3/state 2 respiration) of 8-10, indicating well-coupled mitochondria (Fig. 5A) . The application of the NO donor Sper/NO, which releases NO at defined rates (Fig. 5B) , led to a concentration-dependent inhibition of maximal ADP-induced state 3 respiration (Fig. 5C) . When calculating the predicted time-dependent NO release from Sper/NO (Fig. 5B ) and plotting it against the time-dependent inhibition of O 2 consumption (Fig. 5C) , we calculated NO-dependent inhibition of respiration with average half-inhibitory concentrations (IC 50 ) of 62 nmol l −1 in mouse and 114 nmol l −1 in guinea pig mitochondria, respectively (Fig. 5D) , in good agreement with previous data in synaptosomes (Brown and Cooper, 1994) , but somewhat lower than results obtained in isolated beating hearts (Poderoso et al. 1998) .
To test whether the NO-induced inhibition of respiration affects the redox state of mitochondrial NAD(P)H/NAD(P) + , we measured its autofluorescence in isolated mitochondria in the absence and presence of substrates, ADP an NO, respectively. The addition of substrates (pyruvate/malate) to isolated mitochondria reduced the redox state of NAD(P)H/NAD(P) + , while the addition of ADP led to an oxidation by ß50% (Fig. 5E ) by accelerating NADH-coupled respiration. The addition of Sper/NO at concentrations that induced half-maximal (2.5 μmol l −1 ) or maximal inhibition of ADP-induced respiration (50 μmol l −1 ; Fig. 5C ), respectively, led to a concentration-dependent re-reduction of NAD(P)H/NAD(P) + during ADPstimulated respiration (Fig. 4E) , with a half-maximal effect at 2.5 μmol l −1 Sper/NO. These data indicate that NO-induced inhibition of respiration at the ETC directly affects the redox state of NAD(P)H/NAD(P)
+ by blocking NADH delivery to the ETC.
Effects of endogenous NO formation on mitochondrial redox state
To probe whether endogenous NO production within cardiac myocytes is sufficient to regulate respiration, we next measured the autofluorescence of NAD(P)H/ NAD(P) + and FADH 2 /FAD in isolated mouse cardiac myocytes exposed to a similar protocol under which an increase in cellular NO had been observed (i.e. an increase in stimulation frequency from 0.5 to 5 Hz in the presence of isoproterenol, as in Fig. 3) . In WT myocytes, this physiological increase in workload induced an initial slight oxidation of the NAD(P)H/NAD(P) + and FADH 2 /FAD redox states (Fig. 6A ) and, accordingly, the ratio of NAD(P)H/FAD (as a sensitive index for the mitochondrial redox state that eliminates movement artifacts; Fig. 6B ) at the onset of work, which subsequently recovered over the following 2 min. Previous studies have shown that while the initial oxidation of NAD(P)H is due to ADP-induced acceleration of respiration, its subsequent regeneration is mediated by Ca 2+ -induced stimulation of Krebs cycle dehydrogenases (Brandes & Bers, 1997; Maack et al. 2006; . Accordingly, if endogenous NO formation inhibited respiration, the NAD(P)H/FAD redox state would be more reduced, or in other terms, inhibiting endogenous NO formation should oxidize the NAD(P)/FAD redox state. Addition of the nNOS inhibitor 7-NI to WT myocytes, however, did not affect the NAD(P)H/FAD redox states, either at baseline or in response to an increase in workload ( Figs 6A and B) , when endogenous NO formation was stimulated (Figs 2 and 3) . Similarly, the eNOS inhibitor L-NIO had no effect in WT myocytes (data not shown). Addition of the nNOS inhibitor 7-NI to WT myocytes, however, did not affect the NAD(P)H/FAD redox states, either at baseline or in response to an increase in workload ( Figs 6A and B) , when endogenous NO synthesis was stimulated (Figs 2 and 3) . Similarly, the eNOS inhibitor L-NIO had no effect in WT myocytes (data not shown) and no significant differences in the redox states of NAD(P)H/FAD were observed between nNOS −/− and nNOS +/+ myocytes (Fig. 6C) , or between eNOS −/− and C57/BL6J myocytes (Fig. 6D) . Furthermore, nNOS inhibition with 7-NI in myocytes from eNOS −/− mice did not affect NAD(P)H/FAD redox states compared to eNOS −/− myocytes (Fig. 6E) or to WT myocytes under control conditions (Fig. 6F) . Taken together, these data . Exogenous NO inhibits respiration and reduces the redox state of NAD(P)H/NAD(P) + Mitochondria were isolated from guinea pig or mouse hearts and exposed to substrates (P/M; pyruvate, 5 mmol l −1 and malate, 5 mmol l −1 ) and exposed to ADP (1 mmol l −1 ) and the complex IV inhibitor oligomycin (4 μmol l −1 ), and O 2 concentration was measured by a Clark electrode. A, representative trace. B, predicted release of NO from spermine NONOate (sper/NO) at 30°C. C, O 2 consumption in isolated mouse cardiac mitochondria in the presence of P/M and ADP, and in the absence (0 μM) and presence of increasing concentrations of sper/NO (0.1-50 μM), respectively (n = 4 per group). D, when plotting the predicted, time-dependent NO release from sper/NO in B to the actual rate of respiration at the respective time points in C, a sigmoidal concentration-response relationship was observed, quantifying the inhibitory action of NO on respiration. E, determination of the NAD(P)H/NAD(P) + redox state in isolated mitochondria exposed to P/M and ADP in the absence (0 μM; n = 9) or presence of 2.5 or 50 μmol l −1 sper/NO (n = 12, respectively), exerting half-maximal (2.5 μM) or full inhibition of respiration (50 μM), respectively. At the end of the experiment, mitochondria were exposed to the complex IV inhibitor cyanide (2.5 mmol l −1 ) and dinitrophenol (DNP; 250 μmol l −1 ) to fully reduce or oxidize the NAD(P)H/NAD(P) + redox state, respectively. F, H 2 O 2 emission from mouse cardiac mitochondria determined with amplex red in the absence or presence of P/M, ADP and sper/NO as indicated. The concentrations of Sper/NO are given in μmol l -1 . J Physiol 595.12 indicate that during a physiological increase in cardiomyocyte workload triggered by β-adrenergic stimulation, endogenous NOS-derived NO formation does not regulate mitochondrial respiration.
To further test whether endogenous NO formation interferes with mitochondrial respiration, we determined the mitochondrial membrane potential ( m ), which is established by electron flux along the ETC, in myocytes from nNOS −/− and nNOS +/+ littermates during the same protocol. Again, there were no differences between groups regarding the relative change of m during the protocol (Fig. 7A) or the absolute m in resting myocytes determined by the change in TMRM fluorescence during uncoupling with FCCP and oligomycin (Fig. 7B) . Figure 6 . Effect of endogenous NO formation on NAD(P)H and FAD redox states during β-adrenergic stimulation Isolated mouse cardiac myocytes were exposed to an increase of stimulation frequency from 0.5 to 5 Hz and isoproterenol and autofluorescence of NAD(P)H/NAD(P) + and FADH 2 /FAD determined in the same cells, respectively, in the absence and presence of the nNOS inhibitor 7-NI (2 μmol l −1 ; A) . B, ratio of reduced NAD(P)H to oxidized FAD (data from A) in wild-type myocytes in the absence and presence of the nNOS inhibitor 7-NI. Ratios of reduced NAD(P)H to oxidized FAD in myocytes from nNOS -/-and littermate nNOS +/+ mice (C), eNOS KO mice and WT control mice (D), eNOS KO mice in the absence and presence of the nNOS inhibitor 7-NI (E) and eNOS KO mice in the presence of 7-NI compared to the absence of 7-NI in WT mice (control conditions; F). There were no statistically significant differences between the groups.
Studies on isolated mitochondria from rat liver (Sarkela et al. 2001) or heart (Poderoso et al. 1996) indicated that inhibition of respiration by endo-or exogenous NO increases mitochondrial production of reactive oxygen species (ROS) through reduction of the ETC. It has been unclear, however, whether mitochondrial ROS production would also be enhanced by endogenous NOS-derived NO in live cells. Therefore, we first determined mitochondrial H 2 O 2 emission from isolated mitochondria, using amplex red in the extramitochondrial solution, in the absence and presence of ADP and exogenous NO release from Sper/NO, respectively. At Sper/NO concentrations that inhibited respiration and NAD(P)H reduction by ß80% (i.e. up to 5 μM Sper/NO; Fig. 5C-E) , no increase in H 2 O 2 emission was detected in response to exogenous NO (Fig. 5F ), whereas maximal inhibition of ADP-induced respiration at 50 μmol l −1 Sper/NO (Figs 5C-E) increased H 2 O 2 emission more than 2-fold (Fig. 5F ). Accordingly, in isolated cardiac myocytes loaded with the ROS-sensitive indicator DCF-DA, no change in intracellular ROS production was observed during the physiological stress protocol in nNOS −/− compared to nNOS +/+ littermate myocytes (Fig. 7C) . Since neither DCF nor DAF are completely specific for H 2 O 2 (DCF) or NO (DAF), this latter result, in combination with the findings shown in Fig. 3B , suggests that DAF is unlikely to detect ROS, and DCF is unlikely to detect NO under these conditions. To rule out that the lack of a difference between nNOS Physiol 595.12 found no differences between nNOS −/− and nNOS +/+ littermate myocytes (Fig. 7D) . Taken together, these data indicate that under physiological conditions, endogenous nNOS-derived NO formation does not increase cellular ROS production. Since a previous study detected NO formation stemming from a mitochondria-located nNOS in response to more pronounced cytosolic Ca 2+ elevations (Dedkova & Blatter, 2009 ), we performed similar experiments as reported in Figs 3, 6 and 7, but elevated the extracellular Ca 2+ concentration ([Ca 2+ ] o ) from 1 to 3 mM in the absence or presence of the nNOS-inhibitor 7-NI (Fig. 8) . Elevation of [Ca 2+ ] o shortened diastolic and systolic sarcomere length and, importantly, systolic fractional sarcomere shortening, most likely related to increases of cytosolic Ca 2+ transients (Fig. 8Ai and ii) . This led ; n = 12) as in all other experiments on murine cardiac myocytes, or alternatively at 3 mM [Ca 2+ ] o in the absence (3Ca; n = 15) or presence of the nNOS inhibitor 7-NI (3Ca-7NI; n = 5), respectively. A, systolic and diastolic sarcomere length (i) and fractional sarcomere shortening (ii). B, NO formation (DAF fluorescence, i) or the redox state of NAD(P)H (ii; as F/F 0 ). C, the changes of DAF fluorescence (i) or NAD(P)H autofluorescence (ii) during the first minute of the 5 Hz stimulation in all three groups, compared to the increase in the presence of an excess of NO by addition of Sper/NO at the end of every experiment. D, correlation between the changes of NO ( NO) plotted against the change ( ) of NAD(P)H fluorescence during the first minute of the 5 Hz protocol (data taken from C), respectively. E, representative example (i) or averaged data of the final step (ii) of the whole calibration protocol of NAD(P)H redox state and DAF fluorescence by sequentially adding cyanide (blocking the ETC and reducing NAD(P)H), FCCP (uncoupling the ETC and thereby, oxidizing NAD(P)H) and an excess of NO (by adding spermine NONOate; Sper/NO), respectively. † P < 0.05 (unpaired t-test), # P < 0.05 (two-way ANOVA) and * P < 0.05, * * P < 0.01 and * * * P < 0.001 (Bonferroni's multiple comparisons test), respectively.
to a transient increase in NO formation and a parallel reduction of NAD(P)H during the first minute of 5 Hz stimulation, respectively ( Fig. 8B and C) . There was a close correlation between NO formation and the degree of NAD(P)H reduction within these cells (Fig. 8D ). Both the increase in NO formation and the NAD(P)H reduction were largely prevented by the nNOS-inhibitor 7-NI, without interfering with sarcomere shortening (Fig. 8A) . When applying an excess amount of the NO-donor Sper/NO, this increased DAF fluorescence and substantially reduced the NAD(P)H redox state (Fig. 8E) , comparable with conditions in isolated mitochondria (Fig. 5) . These results indicate that at supra-physiological cytosolic Ca 2+ concentrations, nNOS-derived NO does indeed inhibit respiration and thereby reduces NAD(P)H.
Discussion
The main findings of the present study are that during a physiological increase in workload triggered by β-adrenergic stimulation, the major source for endogenous formation of NO in cardiac myocytes is nNOS, while the contribution of any NOS located within mitochondria, i.e. mtNOS, is unlikely to contribute significantly under these conditions. Furthermore, the amount of intracellular NO produced by nNOS does not affect mitochondrial respiration, the mitochondrial redox state, or ROS production and elimination during workload transitions. At supra-physiological cytosolic Ca 2+ concentrations, however, nNOS-derived NO transiently inhibits respiration and thereby reduces the NAD(P)H redox state. Therefore, our results neither rule out the existence of an mtNOS nor rule out its relevance under pathological conditions, such as mitochondrial Ca 2+ overload (Dedkova & Blatter, 2009; Dedkova et al. 2013) and/or during ischaemia/reperfusion (Burkard et al. 2010) .
No evidence for physiological NO production from an mtNOS
The existence of an mtNOS remains an unresolved and controversial field, with sound data arguing either for (Zaobornyj & Ghafourifar, 2012) or against this concept (Brookes, 2004; Csordás et al. 2007) . While most studies were performed on isolated mitochondria, attempting to detect either an NOS protein and/or NO formation biochemically (Brookes, 2004; Csordás et al. 2007; Zaobornyj & Ghafourifar, 2012) , more recent elegant work by Dedkova & Blatter (2009) provided evidence for an mtNOS in mitochondria of functional cardiac myocytes. An important difference between their study and ours is, however, that Dedkova & Blatter (2009) performed chemical permeabilization of cardiac myocytes to wash out the non-mitochondrial portions of the NO indicator DAF. Under these conditions, the physiological processes of EC coupling can no longer take place and therefore the extra-mitochondrial (i.e. cytosolic) [Ca 2+ ] was clamped to 2 μmol l −1 . Under these conditions, mitochondria accumulate Ca 2+ (Sedova et al. 2006 ) and activate NO formation from an mtNOS (Dedkova & Blatter, 2009 ). An important aspect of their study was that when L-Arg, a key substrate for NOS, was missing in the cytosolic solution, then mtNOS uncoupled, produced superoxide (O 2 − ) instead of NO and this led to activation of the mitochondrial permeability transition pore (mPTP), which is a known trigger for apoptotic or necrotic cell death (Halestrap, 2005) . In contrast to their study, in our present study, we did not permeabilize the cell membrane, but eliminated a similar amount of cytosolic DAF compared to the same cell membrane permeabilization protocol (Fig. 4B) as used by Dedkova & Blatter (2009) . However, under these patch-clamped conditions, addition of L-Arg in the pipette and/or bath solutions was not required to support NO formation, indicating that under these conditions, the cellular environment was well preserved despite the efficient dialysis of DAF from the cytosolic compartment. In all our experiments, the mitochondrial membrane potential ( m ), a sensitive parameter for mPTP opening, remained stable during physiological increases of mitochondrial Ca 2+ Chen et al. 2012 ) and triggering of NO production (Figs 2C, 3, 4D and E) . However, when elevating intracellular Ca 2+ to supra-physiological levels by increasing [Ca 2+ ] o , nNOS-derived NO indeed inhibited respiration and thereby reduced NAD(P)H. Together, these data indicate that while Dedkova & Blatter (2009) created conditions resembling cytosolic and mitochondrial Ca 2+ overload during ischaemia/reperfusion, triggering mPTP opening (Murphy & Steenbergen, 2008) , our conditions rather reflect the situation during a physiological workload transition, during which Ca 2+ rises sufficiently in the cytosol and mitochondria to activate the Ca 2+ -sensitive dehydrogenases of the Krebs cycle (Maack et al. 2006; .
Under our physiological conditions, the MCU inhibitor Ru360 did not prevent the increase in intramitochondrial NO ( Fig. 4C and E) and therefore the NO within mitochondria is unlikely to derive from an NOS that would be activated by intramitochondrial Ca 2+ . This contrasts with the more severe mitochondrial Ca 2+ uptake conditions used by Dedkova & Blatter (2009) , where Ru360 did prevent intramitochondrial NO formation. This indicates that under physiological conditions, no mtNOS is activated, while under pathological conditions with higher mitochondrial Ca 2+ concentrations, mtNOS may become activated. Therefore, our data argue against a physiological role of an mtNOS in cardiac myocytes (Zaobornyj & Ghafourifar, 2012) . This is in agreement with previous data on porcine or human J Physiol 595.12 cardiac mitochondria, in which the rate of a mitochondrial NOS was slower than its inactivation, making a physiological regulatory impact on the ETC unlikely (French et al. 2001; Csordás et al. 2007) .
Nevertheless, we indeed observed that during the physiological stress response triggered by β-adrenergic stimulation, NO increased within mitochondria, and this increase was abrogated by genetic deletion of nNOS ( Fig. 4C-E) . Therefore, we postulate that the nNOS that co-localizes with RyRs in the SR (Xu et al. 1999; Barouch et al. 2002) is the source of this NO, which is feasible given the very close vicinity of the SR and RyRs to mitochondria, constituting an SR-mitochondrial Ca 2+ microdomain governed by tethering proteins such as mitofusin-2 (Fig. 1) (Sharma et al. 2000; Chen et al. 2012; Kohlhaas & Maack, 2013) . Previous biochemical studies revealed that when applying the RyR activator caffeine to isolated mitochondria, sustained increases in intramitochondrial Ca 2+ can be observed (Garcia-Perez et al. 2008) , indicating that it is very difficult to separate the SR and, in particular, mitochondria-associated membranes containing RyRs (Chen et al. 2012 ) from mitochondria. One may therefore speculate that at least in some previous biochemical studies (Brookes, 2004; Zaobornyj & Ghafourifar, 2012) , detection of NOS protein and/or NO production in seemingly purified mitochondria may have been contaminated with portions of the SR containing RyRs and nNOS.
Physiological endogenous NO production does not control respiration
While it is quite well established that endogenous and exogenous NO can principally regulate O 2 consumption in myocardium constitutively in vivo (Shen et al. 1994) , but in particular after hormonal stimulation Loke et al. 1999) and/or ischaemia/reperfusion Xie et al. 1998) , it is unresolved whether this occurs only by paracrine mechanisms from endothelial eNOS and/or also from NOS sources within cardiac myocytes. To our knowledge, our study is the first that has addressed this issue in physiologically beating cardiac myocytes. While it is conceptually intriguing that endogenous NO production within cardiac myocytes -be it from mtNOS, SR-located nNOS and/or caveolae-located eNOS -could control respiration and thereby the mitochondrial redox state of NAD(P)H, the results of our experiments did not indicate that this is actually the case during a physiological situation in which cytosolic and mitochondrial Ca 2+ increase in response to β-adrenergic stimulation. This physiological trigger elevates cytosolic and mitochondrial Ca 2+ to levels sufficient to activate matrix-located dehydrogenases of the Krebs cycle, adapting energy supply to demand (Balaban, 2009; Denton, 2009; Kohlhaas & Maack, 2013) , while mitochondrial Ca 2+ overload, which occurs primarily during ischaemia/reperfusion, can open the permeability transition pore and induce apoptotic and/or necrotic cell death (Halestrap, 2005; Murphy & Steenbergen, 2008) . Therefore, if endogenous NO formation in cardiac myocytes was to regulate respiration under physiological workload changes, one would expect this to be the case within the dynamic physiological range covered by β-adrenergic stimulation in our experiments. Since in isolated mitochondria, exogenous NO-induced inhibition of respiration was directly associated with a reduction of the mitochondrial NAD(P)H/NAD(P) + redox state (Fig. 5) , we feel confident that any relevant endogenous NO-mediated inhibition of respiration should have affected the NAD(P)H/NAD(P) + and FADH 2 /FAD redox states in working cardiac myocytes. However, neither the use of inhibitors nor the use of knock-out technology dismantled such redox regulation (Fig. 6) . Furthermore, also other parameters impacted by mitochondrial respiration and redox changes, such as m and ROS formation, were not affected by nNOS deletion (Fig. 7) . In contrast, supra-physiological Ca 2+ elevations may indeed trigger nNOS-related NO to interfere with respiration (Fig. 8) . Therefore, we postulate that in cardiac myocytes, endogenous NO formation does not control respiration during physiological β-adrenergic stimulation (Fig. 4C) . These data argue against several previous studies but which were performed mostly biochemically with extrapolations to the whole cell or in vivo situation, and were not performed on functioning cells or hearts (Brookes, 2004; Zaobornyj & Ghafourifar, 2012) .
Conclusions
Taken together, the data of our study show that during a physiological workload transition induced by β-adrenergic stimulation, NO increases in the cytosol and mitochondria of cardiac myocytes, which stems from an nNOS that is not located within mitochondria, but presumably on the nearby SR. The amounts of NO, however, are not sufficient to control respiration under these physiological conditions, while during more severe cytosolic Ca 2+ elevations, as may occur during ischaemia/reperfusion, an nNOS-related regulation of respiration occurs. Therefore, we suggest that under physiological conditions, the control of O 2 consumption of the heart is limited to paracrine mechanisms, such as eNOS-derived NO from the coronary microvasculature (Shen et al. 1994; .
